Related Experiment Video
Updated: Jun 27, 2026
07:59
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Management algorithms for stage IIIA non-small cell lung cancer with N2 node involvement
Frank Detterbeck1, Mithran S Sukumar
1Department of Surgery, Section of Thoracic Surgery, Yale University, 333 Cedar Street, FMB 128, P.O. Box 208062, New Haven, CT 06520, USA. frank.detterbeck@yale.edu
Thoracic Surgery Clinics
|December 18, 2008
Summary
Managing stage IIIA non-small cell lung cancer (NSCLC) with N2 node involvement presents challenges due to subgroup variations. This article offers pragmatic algorithms to guide treatment decisions for these complex cases.
Area of Science:
- Oncology
- Thoracic Surgery
- Pulmonary Medicine
Background:
- Stage IIIA non-small cell lung cancer (NSCLC) with N2 node involvement (IIIA[N2]) is complex and controversial.
- Existing data application is hindered by subgroup heterogeneity and limited patient cohort descriptions.
Purpose of the Study:
- To address the confusion surrounding IIIA[N2] NSCLC management.
- To propose pragmatic algorithms for patient management.
Main Methods:
- Review of existing literature and clinical data for IIIA[N2] NSCLC.
- Development of a simplified, practical approach to define management strategies.
- Creation of algorithms for decision-making in IIIA[N2] patient care.
Main Results:
- Identification of the spectrum of disease within stage IIIA[N2] NSCLC.
- Highlighting limitations in current patient cohort descriptions.
- Proposing a framework for applying study data to specific patient subgroups.
Conclusions:
- A pragmatic approach is essential for navigating the complexities of IIIA[N2] NSCLC.
- Defined algorithms can improve the consistent and appropriate application of clinical data.
- Standardized management strategies are needed for this challenging NSCLC stage.
